Kantum Pharma

Developer of therapies for treating acute kidney injury

placeConcord, New Hampshire, United States calendar_todayFounded 2019 language kantumpharma.com

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital3100%
Coming soon